Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 2003 Sep 1;374(Pt 2):463–471. doi: 10.1042/BJ20030240

Expression of melanotransferrin isoforms in human serum: relevance to Alzheimer's disease.

Richard R Desrosiers 1, Yanick Bertrand 1, Quynh-Tran Nguyen 1, Michel Demeule 1, Reinhard Gabathuler 1, Malcolm L Kennard 1, Serge Gauthier 1, Richard Béliveau 1
PMCID: PMC1223615  PMID: 12809550

Abstract

Levels of soluble melanotransferrin in serum have been reported to be higher in patients with Alzheimer's disease than in control subjects. The present study investigated melanotransferrin in human body fluids in the light of these findings. To clarify the correlation between melanotransferrin and Alzheimer's disease, the melanotransferrin content was determined by non-reducing, denaturing SDS/PAGE and Western blotting. Under these conditions, serum melanotransferrin migrated at 79 and 82 kDa. Melanotransferrin antigenicity and the relative proportions of the two forms were very sensitive to factors that altered its conformation, including disulphide bridges, pH and bivalent cations. Serum melanotransferrin levels were not significantly different between control subjects and patients with Alzheimer's disease using whole serum, EDTA-supplemented serum or serum immunoglobulin-depleted by Protein G-Sepharose and enriched by affinity precipitation with the lectin from Asparagus pea. Glycosylated forms of serum melanotransferrin bound to Asparagus lectin manifested similar patterns on two-dimensional gel electrophoresis in samples from controls and Alzheimer's disease subjects. Melanotransferrin was also present in saliva and at a high level in urine, but contents were similar in controls and patients with Alzheimer's disease. Together, these results demonstrate that serum melanotransferrin exists in various conformations depending on the binding of bivalent cations or following post-translational modification. These data also indicate that human serum melanotransferrin levels are unchanged in subjects with Alzheimer's disease.

Full Text

The Full Text of this article is available as a PDF (238.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alemany R., Vilá M. R., Francí C., Egea G., Real F. X., Thomson T. M. Glycosyl phosphatidylinositol membrane anchoring of melanotransferrin (p97): apical compartmentalization in intestinal epithelial cells. J Cell Sci. 1993 Apr;104(Pt 4):1155–1162. doi: 10.1242/jcs.104.4.1155. [DOI] [PubMed] [Google Scholar]
  2. Brown J. P., Hewick R. M., Hellström I., Hellström K. E., Doolittle R. F., Dreyer W. J. Human melanoma-associated antigen p97 is structurally and functionally related to transferrin. Nature. 1982 Mar 11;296(5853):171–173. doi: 10.1038/296171a0. [DOI] [PubMed] [Google Scholar]
  3. Brown J. P., Woodbury R. G., Hart C. E., Hellström I., Hellström K. E. Quantitative analysis of melanoma-associated antigen p97 in normal and neoplastic tissues. Proc Natl Acad Sci U S A. 1981 Jan;78(1):539–543. doi: 10.1073/pnas.78.1.539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Demeule Michel, Poirier Julie, Jodoin Julie, Bertrand Yanick, Desrosiers Richard R., Dagenais Claude, Nguyen Tran, Lanthier Julie, Gabathuler Reinhard, Kennard Malcolm. High transcytosis of melanotransferrin (P97) across the blood-brain barrier. J Neurochem. 2002 Nov;83(4):924–933. doi: 10.1046/j.1471-4159.2002.01201.x. [DOI] [PubMed] [Google Scholar]
  5. Diaz-Arrastia R., Baskin F. New biochemical markers in Alzheimer disease. Arch Neurol. 2001 Mar;58(3):354–356. doi: 10.1001/archneur.58.3.354. [DOI] [PubMed] [Google Scholar]
  6. Feldman H., Gabathuler R., Kennard M., Nurminen J., Levy D., Foti S., Foti D., Beattie B.L., Jefferies W.A. Serum p97 levels as an aid to identifying Alzheimer's disease. J Alzheimers Dis. 2001 Oct;3(5):507–516. doi: 10.3233/jad-2001-3510. [DOI] [PubMed] [Google Scholar]
  7. Food M. R., Rothenberger S., Gabathuler R., Haidl I. D., Reid G., Jefferies W. A. Transport and expression in human melanomas of a transferrin-like glycosylphosphatidylinositol-anchored protein. J Biol Chem. 1994 Jan 28;269(4):3034–3040. [PubMed] [Google Scholar]
  8. Food Michael R., Sekyere Eric O., Richardson Des R. The soluble form of the membrane-bound transferrin homologue, melanotransferrin, inefficiently donates iron to cells via nonspecific internalization and degradation of the protein. Eur J Biochem. 2002 Sep;269(18):4435–4445. doi: 10.1046/j.1432-1033.2002.03140.x. [DOI] [PubMed] [Google Scholar]
  9. Jefferies W. A., Food M. R., Gabathuler R., Rothenberger S., Yamada T., Yasuhara O., McGeer P. L. Reactive microglia specifically associated with amyloid plaques in Alzheimer's disease brain tissue express melanotransferrin. Brain Res. 1996 Mar 11;712(1):122–126. doi: 10.1016/0006-8993(95)01407-1. [DOI] [PubMed] [Google Scholar]
  10. Kennard M. L., Feldman H., Yamada T., Jefferies W. A. Serum levels of the iron binding protein p97 are elevated in Alzheimer's disease. Nat Med. 1996 Nov;2(11):1230–1235. doi: 10.1038/nm1196-1230. [DOI] [PubMed] [Google Scholar]
  11. Kennard M. L., Richardson D. R., Gabathuler R., Ponka P., Jefferies W. A. A novel iron uptake mechanism mediated by GPI-anchored human p97. EMBO J. 1995 Sep 1;14(17):4178–4186. doi: 10.1002/j.1460-2075.1995.tb00091.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kim D. K., Seo M. Y., Lim S. W., Kim S., Kim J. W., Carroll B. J., Kwon D. Y., Kwon T., Kang S. S. Serum melanotransferrin, p97 as a biochemical marker of Alzheimer's disease. Neuropsychopharmacology. 2001 Jul;25(1):84–90. doi: 10.1016/S0893-133X(00)00230-X. [DOI] [PubMed] [Google Scholar]
  13. Kriegerbecková K., Kovár J. Role of melanotransferrin (p97) in non-transferrin iron uptake by HeLa and K562 cells. Folia Biol (Praha) 2000;46(2):77–81. [PubMed] [Google Scholar]
  14. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  15. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E. M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984 Jul;34(7):939–944. doi: 10.1212/wnl.34.7.939. [DOI] [PubMed] [Google Scholar]
  16. Richardson D. R., Baker E. The release of iron and transferrin from the human melanoma cell. Biochim Biophys Acta. 1991 Feb 19;1091(3):294–302. doi: 10.1016/0167-4889(91)90192-z. [DOI] [PubMed] [Google Scholar]
  17. Richardson D. R., Baker E. The uptake of iron and transferrin by the human malignant melanoma cell. Biochim Biophys Acta. 1990 Jun 12;1053(1):1–12. doi: 10.1016/0167-4889(90)90018-9. [DOI] [PubMed] [Google Scholar]
  18. Richardson D. R. The role of the membrane-bound tumour antigen, melanotransferrin (p97), in iron uptake by the human malignant melanoma cell. Eur J Biochem. 2000 Mar;267(5):1290–1298. doi: 10.1046/j.1432-1327.2000.01079.x. [DOI] [PubMed] [Google Scholar]
  19. Richardson D., Baker E. The uptake of inorganic iron complexes by human melanoma cells. Biochim Biophys Acta. 1991 Jun 7;1093(1):20–28. doi: 10.1016/0167-4889(91)90133-i. [DOI] [PubMed] [Google Scholar]
  20. Rose T. M., Plowman G. D., Teplow D. B., Dreyer W. J., Hellström K. E., Brown J. P. Primary structure of the human melanoma-associated antigen p97 (melanotransferrin) deduced from the mRNA sequence. Proc Natl Acad Sci U S A. 1986 Mar;83(5):1261–1265. doi: 10.1073/pnas.83.5.1261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Rothenberger S., Food M. R., Gabathuler R., Kennard M. L., Yamada T., Yasuhara O., McGeer P. L., Jefferies W. A. Coincident expression and distribution of melanotransferrin and transferrin receptor in human brain capillary endothelium. Brain Res. 1996 Mar 11;712(1):117–121. doi: 10.1016/0006-8993(96)88505-2. [DOI] [PubMed] [Google Scholar]
  22. Sekyere E., Richardson D. R. The membrane-bound transferrin homologue melanotransferrin: roles other than iron transport? FEBS Lett. 2000 Oct 13;483(1):11–16. doi: 10.1016/s0014-5793(00)02079-2. [DOI] [PubMed] [Google Scholar]
  23. Sekyere Eric, Food Michael R., Richardson Des R. A second melanotransferrin gene (MTf2) and a novel protein isoform: explanation for the membrane-bound and soluble forms of melanotransferrin? FEBS Lett. 2002 Feb 13;512(1-3):350–352. doi: 10.1016/s0014-5793(02)02248-2. [DOI] [PubMed] [Google Scholar]
  24. Yamada T., Tsujioka Y., Taguchi J., Takahashi M., Tsuboi Y., Moroo I., Yang J., Jefferies W. A. Melanotransferrin is produced by senile plaque-associated reactive microglia in Alzheimer's disease. Brain Res. 1999 Oct 16;845(1):1–5. doi: 10.1016/s0006-8993(99)01767-9. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES